Fiorenzo Albani

Research Profile

Disorders

Chemicals & Drugs

Physiology

Drug Interactions

Procedures

Concepts & Ideas

Drug Dose Response Relationship

Phenomena

Protein Binding

Co-author Network

Publications

TOP 3
Giovanna Lopane; Manuela Contin; Cesa Scaglione; Fiorenzo Albani; Agostino Baruzzi; Paolo Martinelli
The effect of a clinically practical exercise on levodopa bioavailability and motor response in patients with Parkinson disease.
Manuela Contin; Susan Mohamed; Carmina Candela; Fiorenzo Albani; Roberto Riva; Agostino Baruzzi
Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy.
Manuela Contin; Susan Mohamed; Fiorenzo Albani; Roberto Riva; Agostino Baruzzi
Simple and validated HPLC-UV analysis of levetiracetam in deproteinized plasma of patients with epilepsy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Fiorenzo Albani (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Giovanna Lopane; Manuela Contin; Cesa Scaglione; Fiorenzo Albani; Agostino Baruzzi; Paolo Martinelli
The effect of a clinically practical exercise on levodopa bioavailability and motor response in patients with Parkinson disease.
Clinical neuropharmacology 2010;33(5):254-6.
2010: Manuela Contin; Susan Mohamed; Carmina Candela; Fiorenzo Albani; Roberto Riva; Agostino Baruzzi
Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2010;878(3-4):461-5.
2008: Manuela Contin; Susan Mohamed; Fiorenzo Albani; Roberto Riva; Agostino Baruzzi
Simple and validated HPLC-UV analysis of levetiracetam in deproteinized plasma of patients with epilepsy.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2008;873(1):129-32.
2008: Manuela Contin; Paolo Martinelli; Cesa Scaglione; Patrizia Avoni; Fiorenzo Albani; Roberto Riva; Agostino Baruzzi
The effect of entacapone on levodopa rate of absorption and latency to motor response in patients with Parkinson disease.
Clinical neuropharmacology 2008;31(5):267-71.
2007: Fiorenzo Albani; Francesca Bisulli; Marta Bartezaghi; Renato Turrini; Agostino Baruzzi;
Multicentre observational study evaluating immediate and progressive switching from carbamazepine to oxcarbazepine in patients with epilepsy.
Functional neurology 2007;22(2):111-5.
2007: Giuseppe Plazzi; Pasquale Montagna; Federica Provini; Fiorenzo Albani; Roberto Riva
Treatment of narcolepsy with cataplexy.
Lancet 2007;369(9567):1081.
2007: Manueala Contin; Paolo Martinelli; Fiorenzo Albani; Cesa Scaglione; Patrizia Avoni; Giovanni Rizzo; Agostino Baruzzi
Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias.
Clinical neuropharmacology 2007;30(2):122-4.
2006: Marta Maschio; Fiorenzo Albani; Agostino Baruzzi; Alessia Zarabla; Loredana Dinapoli; Andrea Pace; Alfredo Pompili; Carmine Maria Carapella; Emanuele Occhipinti; Bruno Jandolo
Levetiracetam therapy in patients with brain tumour and epilepsy.
Journal of neuro-oncology 2006;80(1):97-100.
2006: Manuela Contin; Fiorenzo Albani; Giovanni Ambrosetto; Patrizia Avoni; Francesca Bisulli; Roberto Riva; Paolo Tinuper; Agostino Baruzzi
Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsy.
Epilepsia 2006;47(9):1573-5.
2006: F Albani; A Baruzzi;
Oxcarbazepine long-term treatment retention in patients switched over from carbamazepine.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2006;27(3):173-5.
2006: Emilio Perucca; Fiorenzo Albani; Giuseppe Capovilla; Bernardo Dalla Bernardina; Roberto Michelucci; Gaetano Zaccara
Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.
Epilepsia 2006;47 Suppl 5():16-20.
2005: Manuela Contin; Monica Balboni; Erica Callegati; Carmina Candela; Fiorenzo Albani; Roberto Riva; Agostino Baruzzi
Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2005;828(1-2):113-7.
2005: F Provini; F Albani; R Vetrugno; L Vignatelli; C Lombardi; G Plazzi; P Montagna
A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2005;12(6):432-6.
2005: Manuela Contin; Paolo Martinelli; Mirella Mochi; Roberto Riva; Fiorenzo Albani; Agostino Baruzzi
Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2005;20(6):734-9.
2004: Manuela Contin; Fiorenzo Albani; Roberto Riva; Agostino Baruzzi
Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
Therapeutic drug monitoring 2004;26(4):375-9.
2004: F Albani; B Grassi; R Ferrara; R Turrini; A Baruzzi;
Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch.
Seizure : the journal of the British Epilepsy Association 2004;13(4):254-63.
2004: Manuela Contin; Paolo Martinelli; Mirella Mochi; Fiorenzo Albani; Roberto Riva; Cesa Scaglione; Maurizio Dondi; Stefano Fanti; Cinzia Pettinato; Agostino Baruzzi
Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease.
Clinical neuropharmacology 2004;27(3):111-5.
2003: Manuela Contin; Paolo Martinelli; Roberto Riva; Maurizio Dondi; Stefano Fanti; Cinzia Pettinato; Cesa Scaglione; Fiorenzo Albani; Agostino Baruzzi
Assessing dopaminergic function in Parkinson's disease: levodopa kinetic-dynamic modeling and SPECT.
Journal of neurology 2003;250(12):1475-81.
2003: P Martinelli; M Contin; C Scaglione; R Riva; F Albani; A Baruzzi
Levodopa pharmacokinetics and dyskinesias: are there sex-related differences?
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2003;24(3):192-3.
2003: Agostino Baruzzi; Manuela Contin; Giovanni Barbara; Cesare Cremon; Roberto De Giorgio; Annalisa Patrizi; Fiorenzo Albani; Roberto Corinaldesi
Drug rash with eosinophilia and systemic symptoms secondary to phenobarbitone.
Clinical neuropharmacology 2003;26(4):177-8.
2003: Manuela Contin; Federica Provini; Paolo Martinelli; Roberto Riva; Fiorenzo Albani; Roberto Vetrugno; Caterina Lombardi; Pasquale Montagna; Agostino Baruzzi
Excessive daytime sleepiness and levodopa in Parkinson's disease: polygraphic, placebo-controlled monitoring.
Clinical neuropharmacology 2003;26(3):115-8.
2003: R Mandrioli; N Ghedini; F Albani; E Kenndler; M A Raggi
Liquid chromatographic determination of oxcarbazepine and its metabolites in plasma of epileptic patients after solid-phase extraction.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2003;783(1):253-63.
2002: Manuela Contin; Simonetta Sangiorgi; Roberto Riva; Antonia Parmeggiani; Fiorenzo Albani; Agostino Baruzzi
Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazam.
Therapeutic drug monitoring 2002;24(6):737-41.
2002: Manuela Contin; Roberto Riva; Fiorenzo Albani; Patrizia Avoni; Agostino Baruzzi
Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
Therapeutic drug monitoring 2002;24(3):332-7.
2001: M Contin; R Riva; P Martinelli; F Albani; P Avoni; A Baruzzi
Levodopa therapy monitoring in patients with Parkinson disease: a kinetic-dynamic approach.
Therapeutic drug monitoring 2001;23(6):621-9.
2001: M Contin; R Riva; F Albani; P Martinelli; A Baruzzi
Pharmacodynamic modeling of oral levodopa in Parkinson's disease.
Annals of neurology 2001;50(5):687-8.
2001: R Mandrioli; F Albani; G Casamenti; C Sabbioni; M A Raggia
Simultaneous high-performance liquid chromatography determination of carbamazepine and five of its metabolites in plasma of epileptic patients.
Journal of chromatography. B, Biomedical sciences and applications 2001;762(2):109-16.
2001: P Avoni; M Contin; R Riva; F Albani; R Liguori; A Baruzzi
Dysgeusia in epileptic patients treated with lamotrigine: report of three cases.
Neurology 2001;57(8):1521.
2001: M Contin; R Riva; F Albani; A Baruzzi
Simple and rapid liquid chromatographic-turbo ion spray mass spectrometric determination of topiramate in human plasma.
Journal of chromatography. B, Biomedical sciences and applications 2001;761(1):133-7.
2000: V Donadio; P Bonsi; I Zele; L Monari; R Liguori; R Vetrugno; F Albani; P Montagna
Myoglobinuria after ingestion of extracts of guarana, Ginkgo biloba and kava.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2000;21(2):124.
1999: M Contin; R Riva; F Albani; A A Baruzzi
Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy.
Therapeutic drug monitoring 1999;21(6):604-8.
1999: M Contin; R Riva; P Martinelli; P Cortelli; F Albani; A Baruzzi
Concentration-effect relationship of levodopa-benserazide dispersible formulation versus standard form in the treatment of complicated motor response fluctuations in Parkinson's disease.
Clinical neuropharmacology 1999;22(6):351-5.
1998: M Contin; R Riva; P Martinelli; P Cortelli; F Albani; A Baruzzi
A levodopa kinetic-dynamic study of the rate of progression in Parkinson's disease.
Neurology 1998;51(4):1075-80.
1998: M Contin; R Riva; P Martinelli; F Albani; A Baruzzi
Effect of meal timing on the kinetic-dynamic profile of levodopa/carbidopa controlled release [corrected] in parkinsonian patients.
European journal of clinical pharmacology 1998;54(4):303-8.
1997: M Contin; R Riva; P Martinelli; F Albani; A Baruzzi
Relationship between levodopa concentration, dyskinesias, and motor effect in parkinsonian patients: a 3-year follow-up study.
Clinical neuropharmacology 1997;20(5):409-18.
1996: R Riva; F Albani; M Contin; A Baruzzi
Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations.
Clinical pharmacokinetics 1996;31(6):470-93.
1996: M Contin; R Riva; F Albani; A Baruzzi
Pharmacokinetic optimisation in the treatment of Parkinson's disease.
Clinical pharmacokinetics 1996;30(6):463-81.
1996: P Avoni; R Riva; F Albani
Recurrence of absence seizures induced by a low dose of amitriptyline: a case report.
European journal of neurology : the official journal of the European Federation of Neurological Societies 1996;3(3):272-4.
1996: M Contin; R Riva; P Martinelli; M Balboni; C Tonello; F Albani; A Baruzzi
Objective assessment of foot strike in Parkinson's disease*.
European journal of neurology : the official journal of the European Federation of Neurological Societies 1996;3(3):221-6.
1996: R Riva; A Cerullo; F Albani; A Baruzzi
Ticlopidine impairs phenytoin clearance: a case report.
Neurology 1996;46(4):1172-3.
1996: M Contin; R Riva; P Martinelli; E J Triggs; F Albani; A Baruzzi
Rate of motor response to oral levodopa and the clinical progression of Parkinson's disease.
Neurology 1996;46(4):1055-8.
1996: E J Triggs; B G Charles; M Contin; P Martinelli; P Cortelli; R Riva; F Albani; A Baruzzi
Population pharmacokinetics and pharmacodynamics of oral levodopa in parkinsonian patients.
European journal of clinical pharmacology 1996;51(1):59-67.
1995: F Albani; R Riva; A Baruzzi
Carbamazepine clinical pharmacology: a review.
Pharmacopsychiatry 1995;28(6):235-44.
1994: P Cortelli; F Albani
Propranolol in prophylaxis of migraine.
Archives of neurology 1994;51(12):1181-2.
1994: G Casucci; A Di Costanzo; R Riva; F Albani; V Bonavita; G Tedeschi
Central action of cinnarizine and flunarizine: a saccadic eye movement study.
Clinical neuropharmacology 1994;17(5):417-22.
1994: M Contin; R Riva; P Martinelli; P Cortelli; F Albani; A Baruzzi
Longitudinal monitoring of the levodopa concentration-effect relationship in Parkinson's disease.
Neurology 1994;44(7):1287-92.
1994: A Baruzzi; F Albani; R Riva
Oxcarbazepine: pharmacokinetic interactions and their clinical relevance.
Epilepsia 1994;35 Suppl 3():S14-9.
1993: M Contin; R Riva; P Martinelli; P Cortelli; F Albani; A Baruzzi
Pharmacodynamic modeling of oral levodopa: clinical application in Parkinson's disease.
Neurology 1993;43(2):367-71.
1993: R Riva; F Albani; G Gobbi; M Santucci; A Baruzzi
Carnitine disposition before and during valproate therapy in patients with epilepsy.
Epilepsia 1993;34(1):184-7.
1993: F Albani; R Riva; A Baruzzi
Clarithromycin-carbamazepine interaction: a case report.
Epilepsia 1993;34(1):161-2.
1992: F Albani; R Riva; M Contin; A Baruzzi
A within-subject analysis of carbamazepine disposition related to development in children with epilepsy.
Therapeutic drug monitoring 1992;14(6):457-60.
1992: M Contin; R Riva; P Martinelli; F Albani; A Baruzzi
No effect of chronic bromocriptine therapy on levodopa pharmacokinetics in patients with Parkinson's disease.
Clinical neuropharmacology 1992;15(6):505-8.
1992: F Albani; R Riva; A Baruzzi
Therapeutic monitoring of antiepileptic drugs. II--Analytical techniques.
Farmaco (Società chimica italiana : 1989) 1992;47(5 Suppl):671-80.
1992: R Riva; F Albani; A Baruzzi
Therapeutic monitoring of antiepileptic drugs. I--Clinical aspects.
Farmaco (Società chimica italiana : 1989) 1992;47(5 Suppl):663-70.
1991: M Contin; R Riva; P Martinelli; G Procaccianti; F Albani; A Baruzzi
Combined levodopa-anticholinergic therapy in the treatment of Parkinson's disease. Effect on levodopa bioavailability.
Clinical neuropharmacology 1991;14(2):148-55.
1991: R Riva; G Zaccara; F Albani; G Galli; R Campostrini; M Paganini; A Baruzzi
Effects of acute valproic acid administration on carnitine plasma concentrations in epileptic patients.
Epilepsy research 1991;8(2):149-52.
1991: F Albani; M R Tamè; R De Palma; M Bernardi
Kinetics of intravenous metoclopramide in patients with hepatic cirrhosis.
European journal of clinical pharmacology 1991;40(4):423-5.
1991: F Albani; W H Theodore; P Washington; O Devinsky; E Bromfield; R J Porter; F J Nice
Effect of felbamate on plasma levels of carbamazepine and its metabolites.
Epilepsia 1991;32(1):130-2.
1991: M Contin; R Riva; P Martinelli; F Albani; A Baruzzi
Effect of age on the pharmacokinetics of oral levodopa in patients with Parkinson's disease.
European journal of clinical pharmacology 1991;41(5):463-6.
1990: F Albani; A Baldrati; P Cortelli; R Riva; A Baruzzi
Flunarizine plasma concentrations and side effects in migraine patients.
Headache 1990;30(6):369-70.
1989: G Zaccara; A Messori; G C Muscas; F Albani; A Baruzzi; A Bianchi; R Riva; T Valenza; P Zagnoni; P Zolo
Predictive performance of pharmacokinetic methods for phenytoin dosing: a multi-center evaluation in 282 patients with epilepsy.
Epilepsy research 1989;3(3):253-61.
1988: P Santanelli; G Gobbi; F Albani; H Gastaut
[Appearance of EEG abnormalities in two patients during long-term treatment with B vitamins].
Neurophysiologie clinique = Clinical neurophysiology 1988;18(6):549-53.
1988: P Cortelli; M Santucci; F Righetti; P Pirazzoli; F Albani; A Baruzzi; T Sacquegna; E Cacciari
Neuroendocrinological evidence of an anti-dopaminergic effect of flunarizine.
Acta neurologica Scandinavica 1988;77(4):289-92.
1987: A Baldrati; F Albani; P de Carolis; T Sacquegna
Essential tremor and flunarizine: description of a case.
Cephalalgia : an international journal of headache 1987;7(4):285.
1987: A Baruzzi; M Contin; R Riva; G Procaccianti; F Albani; C Tonello; E Zoni; P Martinelli
Influence of meal ingestion time on pharmacokinetics of orally administered levodopa in parkinsonian patients.
Clinical neuropharmacology 1987;10(6):527-37.
1987: E Meacci; G La Villa; G Laffi; F Cominelli; M Di Donato; P Dabizzi; F Albani; P Gentilini
Systemic haemodynamics, renal and platelet function during chronic propranolol administration in patients with compensated cirrhosis.
Liver 1987;7(2):110-5.
1987: M Contin; R Riva; F Albani; A Baruzzi
Simple and rapid GLC method for the determination of orphenadrine in human plasma.
Biomedical chromatography : BMC 1987;2(5):193-4.
1987: F Albani; R Riva; M Contin; A Baruzzi
Liquid chromatographic analysis of metoclopramide with fluorescence detection in cirrhotic patients.
Biomedical chromatography : BMC 1987;2(3):135-6.
1986: F Albani; R Riva; G Casucci; M Contin; A Baruzzi
Liquid chromatographic determination of flunarizine in human plasma.
Journal of chromatography 1986;374(1):196-9.
1986: A Baruzzi; M Contin; E Perucca; F Albani; R Riva
Altered serum protein binding of carbamazepine in disease states associated with an increased alpha 1-acid glycoprotein concentration.
European journal of clinical pharmacology 1986;31(1):85-9.
1985: R Riva; M Contin; F Albani; E Perucca; G Procaccianti; A Baruzzi
Free concentration of carbamazepine and carbamazepine-10,11-epoxide in children and adults. Influence of age and phenobarbitone co-medication.
Clinical pharmacokinetics 1985;10(6):524-31.
1985: R Riva; M Contin; F Albani; E Perucca; G Lamontanara; A Baruzzi
Free and total serum concentrations of carbamazepine and carbamazepine-10,11-epoxide in infancy and childhood.
Epilepsia 1985;26(4):320-2.
1985: P Cortelli; M Santucci; F Righetti; P Pirazzoli; E Cacciari; F Albani; A Baldrati; P De Carolis; A Baruzzi; T Sacquegna
Hormonal and metabolic changes induced by flunarizine therapy: preliminary results.
Cephalalgia : an international journal of headache 1985;5 Suppl 2():185-6.
1985: F Albani; R Riva; P Cortelli; M Contin; A Baruzzi
Propranolol plasma binding and serum lipids during chronic therapy in migraine patients.
International journal of clinical pharmacology, therapy, and toxicology 1985;23(5):267-9.
1985: R Riva; F Albani; M Contin; E Perucca; G Ambrosetto; G Gobbi; M Santucci; G Procaccianti; A Baruzzi
Time-dependent interaction between phenytoin and valproic acid.
Neurology 1985;35(4):510-5.
1985: M Contin; R Riva; F Albani; E Perucca; G Lamontanara; A Baruzzi
Alpha 1-acid glycoprotein concentration and serum protein binding of carbamazepine and carbamazepine-10,11 epoxide in children with epilepsy.
European journal of clinical pharmacology 1985;29(2):211-4.
1985: R Riva; M Contin; F Albani; E Perucca; G Ambrosetto; G Procaccianti; M Santucci; A Baruzzi
Lateral gaze nystagmus in carbamazepine-treated epileptic patients: correlation with total and free plasma concentrations of parent drug and its 10,11-epoxide metabolite.
Therapeutic drug monitoring 1985;7(3):277-82.
1985: P Cortelli; T Sacquegna; F Albani; A Baldrati; R D'Alessandro; A Baruzzi; E Lugaresi
Propranolol plasma levels and relief of migraine. Relationship between plasma propranolol and 4-hydroxypropranolol concentrations and clinical effects.
Archives of neurology 1985;42(1):46-8.
1985: R Riva; M Contin; F Albani; A Baruzzi; G Lamontanara
High alpha 1-acid glycoprotein concentrations in serum of epileptic children being treated with carbamazepine.
Clinical chemistry 1985;31(1):150-1.
1985: M Contin; R Riva; F Albani; E Perucca; A Baruzzi
Determination of total and free plasma carbamazepine concentrations by enzyme multiplied immunoassay: interference with the 10,11-epoxide metabolite.
Therapeutic drug monitoring 1985;7(1):46-50.
1984: R Riva; F Albani; G Ambrosetto; M Contin; P Cortelli; E Perucca; A Baruzzi
Diurnal fluctuations in free and total steady-state plasma levels of carbamazepine and correlation with intermittent side effects.
Epilepsia 1984;25(4):476-81.
1984: F Albani; R Riva; M Contin; A Baruzzi
Stereoselective binding of propranolol enantiomers to human alpha 1-acid glycoprotein and human plasma.
British journal of clinical pharmacology 1984;18(2):244-6.
1984: F Albani; R Riva; M Contin; A Baruzzi; M Altomare; G P Merlini; E Perucca
Differential transplacental binding of valproic acid: influence of free fatty acids.
British journal of clinical pharmacology 1984;17(6):759-62.
1984: R Riva; M Contin; F Albani; E Perucca; G Ambrosetto; G Gobbi; P Cortelli; G Procaccianti; A Baruzzi
Free and total plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients: diurnal fluctuations and relationship with side effects.
Therapeutic drug monitoring 1984;6(4):408-13.
1984: F Albani; R Riva; A Baldrati; P Cortelli; E Perucca; G Procaccianti; A Baruzzi
Plasma concentrations of propranolol and 4-hydroxy-propranolol at steady-state in neurological patients: intersubject and intrasubject correlations with dose.
International journal of clinical pharmacology research 1984;4(1):19-23.
1984: F Albani; R Riva; M Contin; A Baruzzi
Valproic acid binding to human serum albumin and human plasma: effects of pH variation and buffer composition in equilibrium dialysis.
Therapeutic drug monitoring 1984;6(1):31-3.
1984: R Riva; F Albani; M Contin; A Baruzzi; M Altomare; G P Merlini; E Perucca
Mechanism of altered drug binding to serum proteins in pregnant women: studies with valproic acid.
Therapeutic drug monitoring 1984;6(1):25-30.
1983: R Riva; F Albani; E Franzoni; E Perucca; M Santucci; A Baruzzi
Valproic acid free fraction in epileptic children under chronic monotherapy.
Therapeutic drug monitoring 1983;5(2):197-200.
1983: R Riva; F Albani; P Cortelli; G Gobbi; E Perucca; A Baruzzi
Diurnal fluctuations in free and total plasma concentrations of valproic acid at steady state in epileptic patients.
Therapeutic drug monitoring 1983;5(2):191-6.
1983: F Albani; R Riva; A Baruzzi; R Calliva; A Frascari; M M Spoto
Valproic acid does not interfere with an enzymatic determination of free fatty acids in plasma.
Clinical chemistry 1983;29(6):1322-3.
1983: P Bollini; R Riva; F Albani; N Ida; L Cacciari; C Bollini; A Baruzzi
Decreased phenytoin level during antineoplastic therapy: a case report.
Epilepsia 1983;24(1):75-8.
1983: F Albani; R Riva; G Procaccianti; A Baruzzi; E Perucca
Free fraction of valproic acid: in vitro time-dependent increase and correlation with free fatty acid concentration in human plasma and serum.
Epilepsia 1983;24(1):65-73.
1982: R Riva; F Albani; F Olivi; M Pantaloni; A Baruzzi
Quantitative determination of n-dipropylacetamide in the plasma of epileptic patients by gas--liquid chromatography with nitrogen-selective detection.
Journal of chromatography 1982;233():371-4.
1982: F Albani; R Riva; E Perucca; A Baruzzi
Interference of valproic acid in the colorimetric determination of free fatty acids in plasma.
Clinical chemistry 1982;28(6):1398.
1982: F Albani; R Riva; A Baruzzi
Simple and rapid determination of propranolol and its active metabolite, 4-hydroxypropranolol, in human plasma by liquid chromatography with fluorescence detection.
Journal of chromatography 1982;228():362-5.
1982: R Riva; F Albani; A Baruzzi; I Galvani; E Perucca
Determination of unbound valproic acid concentration in plasma by equilibrium dialysis and gas--liquid chromatography: methodological aspects and observations in epileptic patients.
Therapeutic drug monitoring 1982;4(4):341-52.
1982: R Riva; F Albani; A Baruzzi
Rapid and simple GLC determination of valproic acid and ethosuximide in plasma of epileptic patients.
Journal of pharmaceutical sciences 1982;71(1):110-1.
1982: R Riva; F Albani; A Baruzzi
Quantitative determination of camazepam and its metabolite temazepam in man by gas-liquid chromatography with electron-capture detection.
Il Farmaco; edizione pratica 1982;37(1):15-9.
1981: G Procaccianti; F Albani; R Riva; A Baruzzi
[Relative bioavailability of phenytoin and barbiturates in single or combined preparations].
Bollettino chimico farmaceutico 1981;120(12):725-9.
1981: F Albani; P Pazzaglia; G Procaccianti; R Riva; A Baruzzi
[Bioavailability of phenytoin. Comparison of data obtained in vitro, in healthy volunteers and in epileptic patients].
Bollettino chimico farmaceutico 1981;120(12):715-24.
1981: R Riva; G Tedeschi; F Albani; A Baruzzi
Quantitative determination of clobazam in the plasma of epileptic patients by gas-liquid chromatography with electron-capture detection.
Journal of chromatography 1981;225(1):219-24.
1981: R Riva; M de Anna; F Albani; A Baruzzi
Rapid quantitation of flurazepam and its major metabolite, N-desalkylflurazepam, in human plasma by gas-liquid chromatography with electron-capture detection.
Journal of chromatography 1981;222(3):491-5.
1980: R Riva; F Albani; A Baruzzi
Rapid quantitative determination of underivatized carbamazepine, phenytoin, phenobarbital and p-hydroxyphenobarbital in biological fluids by packed column gas chromatography.
Journal of chromatography 1980;221(1):75-84.